Pulmonary clinical applications for mesenchymal stem cells

Abstract

Lung disease remains a significant health and economic burden to societies throughout the world and is projected to increase in prevalence. Recent medical advances have enhanced clinical care but further research is needed in the areas of inhibition of lung fibrosis, altering airway inflammation and manipulating the pulmonary vascular endothelium. Stem cells have the potential to address these deficiencies by their remarkable ability to differentiate into various tissue lines and regulate internal repair systems. These unique regenerative abilities provide a novel approach to management for those suffering from pulmonary disease.